Treatment with ledipasvir-sofosbuvir for 12 or 24 weeks in kidney transplant recipients with chronic hepatitis C virus genotype 1 or 4 infection: a randomized trial
Publication Type:
Journal Article
Authors:
Colombo, Massimo;
Aghemo, Alessio;
Liu, Hong;
Zhang, Jie;
Dvory-Sobol, Hadas;
Hyland, Robert;
Yun, Chohee;
Massetto, Benedetta;
Brainard, Diana M.;
McHutchison, John G.;
Bourliere, Marc;
Peck-Radosavljevic, Markus;
Manns, Michael;
Pol, StanislasSource:
Ann Intern Med, Volume 166, Issue 2, p.109-117 (2017)
Keywords:
Adult,
Aged,
Antiviral Agents,
Benzimidazoles,
Drug Administration Schedule,
Drug Resistance, Viral,
Drug Therapy, Combination,
Female,
Fluorenes,
Genotype,
Glomerular Filtration Rate,
Hepatitis C, Chronic,
Humans,
Immunosuppressive Agents,
Kidney Transplantation,
Male,
Middle Aged,
sofosbuvir
